Physician profile
Brian D Williamson
NPI 1255313268
$64,517.00
in general payments reported to CMS, 2019-2025
26 companies · $22K in 2025
The $22K reported for 2025 was more than what 90% of Clinical Cardiac Electrophysiology providers received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,014 · 2020: $1,231 · 2021: $6,140 · 2022: $16K · 2023: $6,313 · 2024: $9,003 · 2025: $22K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $16K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $8,875 · Food and Beverage: $8,270 · Consulting Fee: $3,852 · Education: $12.41.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $15,979.34 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $8,875.00 |
| Food and Beverage | $8,269.64 |
| Consulting Fee | $3,851.69 |
| Education | $12.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $18,289.57 | 2019-2025 | Farapulse, S-Icd System Magnet, Emblem Mri S-Icd |
| Medtronic, INC. | $17,722.74 | 2021-2025 | Evera Mri Xt Dr Surescan, Micra, Affera Mapping System |
| Biosense Webster, INC. | $10,535.23 | 2019-2025 | Carto 3, Na, Qdot Micro Catheter |
| Medical Device Business Services, INC. | $5,714.54 | 2019-2024 | Carto 3 |
| Abbott Laboratories | $4,054.87 | 2019-2024 | Aveir, Jot Dx |
| Sanofi-Aventis U.S. LLC | $3,198.90 | 2019-2022 | |
| Biotronik INC. | $2,238.95 | 2025 | Acticor 7 Vr-T Dx, Amvia Edge |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $539.24 | 2019-2025 | Lifevest |
| Janssen Pharmaceuticals, INC | $491.02 | 2019-2021 | |
| Medtronic Vascular, INC. | $476.57 | 2019-2020 | |
| Pfizer INC. | $347.37 | 2019-2023 | |
| Amgen INC. | $340.24 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $172.08 | 2019-2021 | |
| E.R. Squibb & Sons, L.L.C. | $110.80 | 2019-2023 | |
| Preventice Services, LLC | $69.63 | 2019-2020 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Braemar Manufacturing, LLC | $37.03 | 2019 | |
| Kestra Medical Technology Services, INC. | $33.29 | 2023 | Assure Wcd |
| Merck Sharp & Dohme LLC | $22.47 | 2021 | |
| Alnylam Pharmaceuticals INC. | $19.28 | 2021 | |
| Cardiva Medical, INC. | $17.11 | 2024 | Cardiva Vascade Mvp Vvcs 6-12f |
| Teleflex LLC | $16.57 | 2023 | Langston |
| Astrazeneca Pharmaceuticals LP | $15.84 | 2020 | |
| Amarin Pharma, INC. | $15.02 | 2021 | |
| Cordis US Corp. | $13.73 | 2023 | Rain Sheath Transradial |
| Gilead Sciences, INC. | $13.52 | 2019 | |
| Bardy Diagnostics, INC. | $11.39 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Williamson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.